Developmental & Behavioral Pediatrics Consultants, Inc – Trademark Portfolio
Entity Type: 03
Developmental & Behavioral Pediatrics Consultants, Inc holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include TRIDAS EWRITER. The owner is based in Tampa, FL.
4144 N. Armenia Ave., Suite 375
Tampa, FL 33607
Showing of trademarks Trademarks
Trademark Classifications
Developmental & Behavioral Pediatrics Consultants, Inc's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Developmental & Behavioral Pediatrics Consultants, Inc have?
Developmental & Behavioral Pediatrics Consultants, Inc has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Developmental & Behavioral Pediatrics Consultants, Inc file in?
Developmental & Behavioral Pediatrics Consultants, Inc files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Developmental & Behavioral Pediatrics Consultants, Inc's most well-known trademarks?
Developmental & Behavioral Pediatrics Consultants, Inc's registered trademark portfolio includes well-known marks such as TRIDAS EWRITER. These are among 1 currently registered trademark in the portfolio.
What is Developmental & Behavioral Pediatrics Consultants, Inc's trademark registration success rate?
Developmental & Behavioral Pediatrics Consultants, Inc has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.